Variant report
Variant | esv2059440 |
---|---|
Chromosome Location | chr4:160479875-160480286 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs373553207 | chr4:160479891-160479892 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs144877750 | chr4:160479918-160479919 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs552201173 | chr4:160479929-160479930 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs527450049 | chr4:160479944-160479945 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs4493488 | chr4:160479949-160479950 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
6 | rs182473650 | chr4:160479956-160479957 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs563250813 | chr4:160479963-160479964 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs548280598 | chr4:160479964-160479965 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs145828217 | chr4:160479966-160479967 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs369309330 | chr4:160479995-160479996 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs372622110 | chr4:160480029-160480030 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs568532525 | chr4:160480051-160480052 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs532195600 | chr4:160480056-160480057 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs386681268 | chr4:160480057-160480058 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs551891250 | chr4:160480063-160480064 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs13137785 | chr4:160480068-160480069 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs200950343 | chr4:160480090-160480091 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs534407180 | chr4:160480096-160480097 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs374813192 | chr4:160480102-160480103 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs4607168 | chr4:160480104-160480105 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
21 | rs570799020 | chr4:160480108-160480109 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs374521141 | chr4:160480132-160480133 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs539789022 | chr4:160480154-160480155 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs187474295 | chr4:160480165-160480166 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs576060762 | chr4:160480192-160480193 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs541932462 | chr4:160480196-160480197 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs540566569 | chr4:160480286-160480287 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Acute lymphoblastic leukemia | 22237106 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Chordoma | 21602918 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Breast cancer | 21858162 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Gastric cancer | 21586687 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
4q-syndrome | 17576883 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Muscular dystrophy | 21149563 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cervical cancer | 21062161 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Breast cancer | 16608533 | CNVD |
Lung cancer | 19208797 | CNVD |
Wilms tumour | 21544195 | CNVD |
Lung cancer | 18438408 | CNVD |
Cancer | 22429812 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
primary effusion lymphomas | 17116491 | CNVD |
Breast cancer | 16272173 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 17133270 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Congenital anomalies of the kidney and urinary tract | 20505237 | CNVD |
Breast cancer | 17393978 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Breast cancer | 21785460 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
small cell lung cancer | 20016488 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Breast cancer | 21633010 | CNVD |
T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Cancer | 20581869 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Breast cancer | 20409316 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Cancer | 20164919 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Breast cancer | 21364760 | CNVD |
Schizophrenia | 19805367 | CNVD |
Lung cancer | 20668451 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr4:160478800-160480000 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
2 | chr4:160479000-160480000 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
3 | chr4:160479400-160480600 | Enhancers | Breast Myoepithelial Primary Cells | Breast |
4 | chr4:160479600-160506800 | Weak transcription | Foreskin Keratinocyte Primary Cells skin03 | Skin |